Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022

SELL
$108.42 - $129.58 $308,997 - $369,303
-2,850 Closed
0 $0
Q2 2021

Aug 12, 2021

SELL
$152.95 - $173.41 $3.82 Million - $4.34 Million
-25,000 Reduced 89.77%
2,850 $458,000
Q1 2021

May 13, 2021

SELL
$148.16 - $159.71 $61.4 Million - $66.2 Million
-414,700 Reduced 93.71%
27,850 $4.46 Million
Q4 2020

Feb 12, 2021

SELL
$128.25 - $151.41 $8.44 Million - $9.96 Million
-65,800 Reduced 12.94%
442,550 $68.2 Million
Q3 2020

Nov 17, 2020

SELL
$113.59 - $141.68 $1.14 Million - $1.42 Million
-10,000 Reduced 1.93%
508,350 $69.2 Million
Q2 2020

Aug 10, 2020

SELL
$87.02 - $133.4 $1.35 Million - $2.07 Million
-15,500 Reduced 2.9%
518,350 $61.9 Million
Q1 2020

May 13, 2020

BUY
$78.28 - $155.73 $3.64 Million - $7.24 Million
46,500 Added 9.54%
533,850 $54 Million
Q4 2019

Feb 04, 2020

SELL
$127.4 - $146.83 $191,100 - $220,245
-1,500 Reduced 0.31%
487,350 $72.9 Million
Q3 2019

Oct 29, 2019

BUY
$113.33 - $138.46 $1.53 Million - $1.87 Million
13,500 Added 2.84%
488,850 $67.1 Million
Q2 2019

Jul 24, 2019

BUY
$108.87 - $125.09 $489,915 - $562,905
4,500 Added 0.96%
475,350 $56 Million
Q4 2018

Feb 13, 2019

BUY
$94.4 - $126.76 $44.4 Million - $59.7 Million
470,850 New
470,850 $48.8 Million
Q3 2018

Nov 14, 2018

SELL
$108.41 - $127.64 $51 Million - $60.1 Million
-470,850 Closed
0 $0
Q2 2018

Aug 13, 2018

BUY
$102.12 - $114.04 $48.1 Million - $53.7 Million
470,850 New
470,850 $52.5 Million
Q1 2018

May 10, 2018

BUY
$104.31 - $124.46 $6.26 Million - $7.47 Million
60,000 Added 13.46%
505,850 $55.2 Million
Q4 2017

Feb 13, 2018

SELL
$105.55 - $120.83 $46 Million - $52.7 Million
-435,850 Closed
0 $0
Q3 2017

Oct 27, 2017

BUY
$106.92 - $117.79 $46.6 Million - $51.3 Million
435,850
435,850 $51 Million

Others Institutions Holding ZBH

About ZIMMER BIOMET HOLDINGS, INC.


  • Ticker ZBH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 209,820,000
  • Market Cap $21.3B
  • Description
  • Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...
More about ZBH
Track This Portfolio

Track Schwartz Investment Counsel Inc Portfolio

Follow Schwartz Investment Counsel Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schwartz Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Schwartz Investment Counsel Inc with notifications on news.